IGF1 and type 1 diabetes mellitus: We hypothesized that: (1) IGF-1 and IGFBP-3 levels are decreased in T1DM and elevated by metformin, and (2) miR-106b-3p expression in CFU-Hills is upregulated in T1DM while downregulated by metformin.